Insiders / Myles David C. / Activity
Activity — Myles David C.
11 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jan 13, 2026 | Sell | OLMA Olema Pharmaceuticals, Inc. Common Stock | $1.37M | -50K -8.40% | 542,961 0.62% of shares | medium |
| Jan 14, 2026 | Sell | OLMA Olema Pharmaceuticals, Inc. Common Stock | $1.01M | -35K -6.06% | 542,761 0.62% of shares | medium |
| Jan 14, 2026 | Sell | OLMA Olema Pharmaceuticals, Inc. Common Stock | $428.9K | -15K -2.53% | 577,764 0.66% of shares | medium |
| Jan 12, 2026 | Sell | OLMA Olema Pharmaceuticals, Inc. Common Stock | $283.4K | -10K -6.46% | 144,846 0.17% of shares | medium |
| Jan 14, 2026 | Exercise | OLMA Olema Pharmaceuticals, Inc. Common Stock | $243.5K | +50K +9.21% | 592,761 0.68% of shares | low |
| Jan 13, 2026 | Exercise | OLMA Olema Pharmaceuticals, Inc. Common Stock | $243.5K | +50K +9.21% | 592,761 0.68% of shares | low |
| Jan 13, 2026 | Sell | OLMA Olema Pharmaceuticals, Inc. Common Stock | $5.7K | -200 -0.04% | 542,761 0.62% of shares | low |
| Feb 2, 2026 | Grant | OLMA Olema Pharmaceuticals, Inc. Performance Stock Options (Right to Buy) | — | +106K | 106,250 0.12% of shares | low |
| Feb 2, 2026 | Grant | OLMA Olema Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | +250K | 250,000 0.29% of shares | low |
| Jan 14, 2026 | Exercise | OLMA Olema Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | -50K -50.00% | 50,000 0.06% of shares | low |
| Jan 13, 2026 | Exercise | OLMA Olema Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | -50K -33.33% | 100,000 0.11% of shares | low |